Clinical Trial Update: Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

View source ↗

Summary

A completed clinical trial comparing allogeneic hematopoietic cell transplantation to chemotherapy in older AML patients, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Status: COMPLETED | Results posted: 2019-11-15